Wells Fargo mpany : Results of Operations and Financial Condition - Form 8-K
News Release | April 14, 2023 Wells Fargo... | April 14, 2023
Stay updated with breaking news from Sheet Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
News Release | April 14, 2023 Wells Fargo... | April 14, 2023
SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following summary unaudited pro forma condensed combined financial information presents the combination... | March 24, 2023
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2,... | March 23, 2023
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2, HERKULES-3, FLAGSHP-1, and THUNDERBBOLT-1 trials ...
Net earnings were $737.4 million, or $0.73 per diluted share for the third quarter of fiscal 2023 compared with $746.4 million, or $0.70 per diluted share for...